You have 9 free searches left this month | for more free features.

KPT-9274

Showing 1 - 25 of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • KPT-9274
  • +2 more
  • Los Angeles, California
  • +7 more
Jan 18, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Aurora (KPT-9274)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • KPT-9274
  • Aurora, Colorado
  • +1 more
Aug 30, 2021

Solid Tumor, Non-Hodgkin's Lymphoma Trial in China, Taiwan (ATG-019, ATG-019 + Niacin ER)

Recruiting
  • Solid Tumor, Non-Hodgkin's Lymphoma
  • Nanjing, Jiangsu, China
  • +7 more
Aug 11, 2022

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • (no location specified)
Jan 19, 2023

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +77 more
Jan 24, 2023

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)

Withdrawn
  • Solid Tumor Malignancy
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
Dec 14, 2021

Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

Terminated
  • Glioblastoma
  • Glioma
  • Boston, Massachusetts
  • +5 more
Jan 24, 2023

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Suspended
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +4 more
  • Detroit, Michigan
  • +1 more
Feb 2, 2022

Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)

Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

MDS Trial in New York (selinexor (KPT-330))

Completed
  • Myelodysplastic Syndromes
  • selinexor (KPT-330)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 11, 2022

Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)

Completed
  • Coronavirus Infection
  • Los Angeles, California
  • +32 more
Oct 27, 2021

Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Prostate Cancer Trial in Houston (Selinexor)

Terminated
  • Prostate Cancer
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 7, 2021

Multiple Myeloma Trial in Washington, Hackensack (Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG)

Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Washington, District of Columbia
  • +1 more
Feb 3, 2022

Ovarian Cancer, Endometrial Cancer Trial in Middletown, Harrison, New York (Paclitaxel, Carboplatin, Selinexor)

Completed
  • Ovarian Cancer
  • Endometrial Cancer
  • Middletown, New Jersey
  • +2 more
Apr 22, 2021

Healthy Trial in Melbourne (Verdinexor, Placebo)

Terminated
  • Healthy
  • Melbourne, Victoria, Australia
    Nucleus Network
Mar 18, 2021

Breast Cancer Trial in Tampa (Selinexor)

Completed
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020

Solid Tumors Trial in Singapore (KPT-330)

Completed
  • Solid Tumors
  • Singapore, Singapore
    National University Hospital
Sep 8, 2020

Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Relapsed and/or Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2020

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021